Vanderbilt-Ingram Cancer Center

Surgeons target pancreatic cancer with electrons using new technology

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.

Novel lung cancer biomarker

Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.

New approach outperforms existing cancer susceptibility models

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.

Lovly receives Asclepios Award from GO2 for Lung Cancer

Vanderbilt’s Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.

“VUMC Remembers” virtual memorial service honors patients who died in the past year

The program features speakers from different hospital departments, staff testimonials of patients at the end of their lives, a reading of loved ones’ names and special music.

Surgery for hereditary breast cancer

Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

1 10 11 12 13 14 28